Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scientists find HIV-blocking protein in monkeys

26.02.2004


Organization of the HIV-1 Virion
Credit NIAID


Scientists at the Dana-Farber Cancer Institute have identified a protein that blocks HIV replication in monkey cells. Humans have a similar protein, although it is not as effective at stopping HIV, say the researchers whose work is published in this week’s issue of Nature. The team, headed by Joseph Sodroski, M.D., is supported by the NIH’s National Institute of Allergy and Infectious Diseases (NIAID).

"Identification of this HIV-blocking factor opens new avenues for intervening in the early stage of HIV infection, before the virus can gain a toehold," says NIAID Director Anthony S. Fauci, M.D. "The discovery also gives us critical insights about viral uncoating, a little understood step in the viral lifecycle. Basic discoveries like this provide the scientific springboard to future improvements in therapies for HIV disease."

"Over the years," notes Dr. Sodroski, "we’ve learned quite a bit about how HIV enters cells. More recently, we’ve developed a picture of the late stages of the viral lifecycle, as it leaves the cell. However, the steps between virus entry and conversion of the viral RNA into DNA have been a black box." A key preparatory step is the removal, or uncoating, of the protective shell surrounding HIV’s genetic material. This coat, called the capsid, must be removed before HIV can insert its genetic material into the host cell’s DNA and begin to make copies of itself. (See http://www.niaid.nih.gov/newsroom/graphics/hiv1.jpg for a simplified diagram of HIV, including the capsid.)



The discovery of this host protein helps pry open the black box of uncoating. Called TRIM5-alpha, it is the first found to specifically target HIV’s capsid. With the identification of a specific protein that powerfully inhibits viral uncoating, says Dr. Sodroski, comes the possibility of manipulating and enhancing its activity. For example, he notes, humans have a version of TRIM5-alpha. While it is not as efficient as the simian version, it does have some HIV-blocking ability. "Perhaps this protein could be induced to greater activity, thereby increasing the level of resistance to HIV infection," says Dr. Sodroski.

The discovery could also shorten the path to an AIDS vaccine by making improved animal models of HIV disease possible. Because monkeys are not susceptible to the human version of AIDS, results of vaccine trials conducted on them are not directly applicable to humans. Now with a better understanding of why HIV cannot successfully infect monkey cells, scientists have a defined target to manipulate and could use that information to develop animal models that more closely mimic HIV disease.

Matthew Stremlau, Ph.D., a member of Dr. Sodroski’s team and lead author on the new paper, searched the rhesus monkey genome and isolated a stretch of DNA that encodes the TRIM5-alpha protein. In a series of experiments using lab-grown cells that either possessed or lacked TRIM5-alpha, the scientists determined that TRIM5-alpha is both necessary and sufficient to block HIV replication. Although the precise mechanism of TRIM5-alpha’s activity is not fully determined, says Dr. Sodroski, it may be that the protein chops up HIV’s capsid and thwarts the orderly uncoating the virus must undergo before proceeding to replicate.

"This is a very exciting finding," says NIAID’s Nabila Wassef, Ph.D., a program officer in NIAID’s Division of AIDS. "TRIM5-alpha strikes at the heart of HIV, preventing it from becoming an established infection. As we know, HIV disease can be treated, but not cured. In part this is due to the ability of HIV to take up permanent residence in the body. If we could find a way to disable the virus before it has a chance to replicate, this problem of latent infection would be eliminated."

NIAID is a component of the National Institutes of Health (NIH), an agency of the U.S. Department of Health and Human Services. NIAID supports basic and applied research to prevent, diagnose and treat infectious diseases such as HIV/AIDS and other sexually transmitted infections, influenza, tuberculosis, malaria and illness from potential agents of bioterrorism. NIAID also supports research on transplantation and immune-related illnesses, including autoimmune disorders, asthma and allergies.


Reference: M Stremlau et al. The cytoplasmic body component TRIM5-á restricts HIV-1 infection in Old World monkeys. Nature 427:848-53 (2004).

Press releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.

Anne A. Oplinger | EurekAlert!
Further information:
http://www.niaid.nih.gov

More articles from Life Sciences:

nachricht New eDNA technology used to quickly assess coral reefs
18.04.2019 | University of Hawaii at Manoa

nachricht New automated biological-sample analysis systems to accelerate disease detection
18.04.2019 | Polytechnique Montréal

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Explosion on Jupiter-sized star 10 times more powerful than ever seen on our sun

A stellar flare 10 times more powerful than anything seen on our sun has burst from an ultracool star almost the same size as Jupiter

  • Coolest and smallest star to produce a superflare found
  • Star is a tenth of the radius of our Sun
  • Researchers led by University of Warwick could only see...

Im Focus: Quantum simulation more stable than expected

A localization phenomenon boosts the accuracy of solving quantum many-body problems with quantum computers which are otherwise challenging for conventional computers. This brings such digital quantum simulation within reach on quantum devices available today.

Quantum computers promise to solve certain computational problems exponentially faster than any classical machine. “A particularly promising application is the...

Im Focus: Largest, fastest array of microscopic 'traffic cops' for optical communications

The technology could revolutionize how information travels through data centers and artificial intelligence networks

Engineers at the University of California, Berkeley have built a new photonic switch that can control the direction of light passing through optical fibers...

Im Focus: A long-distance relationship in femtoseconds

Physicists observe how electron-hole pairs drift apart at ultrafast speed, but still remain strongly bound.

Modern electronics relies on ultrafast charge motion on ever shorter length scales. Physicists from Regensburg and Gothenburg have now succeeded in resolving a...

Im Focus: Researchers 3D print metamaterials with novel optical properties

Engineers create novel optical devices, including a moth eye-inspired omnidirectional microwave antenna

A team of engineers at Tufts University has developed a series of 3D printed metamaterials with unique microwave or optical properties that go beyond what is...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Revered mathematicians and computer scientists converge with 200 young researchers in Heidelberg!

17.04.2019 | Event News

First dust conference in the Central Asian part of the earth’s dust belt

15.04.2019 | Event News

Fraunhofer FHR at the IEEE Radar Conference 2019 in Boston, USA

09.04.2019 | Event News

 
Latest News

New automated biological-sample analysis systems to accelerate disease detection

18.04.2019 | Life Sciences

Explosion on Jupiter-sized star 10 times more powerful than ever seen on our sun

18.04.2019 | Physics and Astronomy

New eDNA technology used to quickly assess coral reefs

18.04.2019 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>